文献速递免疫规划传染病防控与疫情报告

鞭毛钩蛋白FlgE:基因组学方法鉴定出的铜绿假单胞菌新型疫苗候选抗原

Flagella hook protein FlgE is a novel vaccine candidate of Pseudomonas aeruginosa identified by a genomic approach.
PubMed 文献 · Vaccine · 2021-03-26

本研究构建了铜绿假单胞菌全基因组蛋白片段文库,利用感染康复患者血清筛选出新型保护性抗原FlgE(鞭毛钩结构组分)。重组FlgE免疫可诱导以Th2为主的免疫应答,降低感染小鼠细菌载量和炎症;抗FlgE抗体可识别天然FlgE并通过调理吞噬杀伤和抑制细菌运动提供保护,与rePcrVNH联用可增强保护效果。

要点

  • FlgE是经全基因组文库和康复者血清筛选出的铜绿假单胞菌保护性抗原。
  • reFlgE免疫诱导Th2优势应答,降低感染小鼠细菌载量和炎症。
  • 抗reFlgE抗体通过调理吞噬杀伤和抑制细菌运动发挥保护作用。

核心结论

  • FlgE是铜绿假单胞菌有前景的疫苗候选抗原,该策略可用于其他病原体抗原的高效筛选。

研究设计与样本

  • 研究构建了带麦芽糖结合蛋白(MBP)标签的铜绿假单胞菌全基因组蛋白片段文库。
  • 利用铜绿假单胞菌感染后康复患者血清筛选保护性抗原,并在小鼠中评估重组FlgE的免疫保护效果。

主要发现

  • reFlgE免疫诱导以Th2为主的免疫应答,并降低铜绿假单胞菌感染小鼠的细菌载量和炎症。
  • 抗reFlgE抗体在体外识别细菌膜上的天然FlgE,并在小鼠中提供保护,可能通过调理吞噬杀伤和抑制细菌运动介导。
  • reFlgE与先前报道的工程抗原rePcrVNH联用可提供更高的抗铜绿假单胞菌感染保护。

临床怎么用

  • FlgE可作为铜绿假单胞菌疫苗的候选抗原进一步开发。
  • 全基因组文库结合康复者血清的筛选策略可用于其他病原体保护性抗原的发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Infections due to Pseudomonas aeruginosa (PA) are becoming a serious threat to patients in intensive care units. A PA vaccine is a practical and economical solution to solve the problems caused by PA infection successfully. In recent years, several antigen candidates have been tested in animal and human clinical trials, but none of them has been approved to date. An alternative strategy for antigen screening and protective antigens is in urgent demand. In this study, we generated a genome-wide library of PA protein fragments tagged with maltose-binding protein (MBP). Using sera from patients who recovered after PA infection, we identified a novel protective antigen, FlgE, which is the structural component of the flagella hook. Vaccination with recombinant FlgE (reFlgE) induced a Th2-predominant immune response and reduced bacterial load and inflammation in PA-infected mice. Anti-reFlgE antibodies recognized native FlgE on the bacterial membrane in vitro and conferred protection in mice, which may be due to the mediation of opsonophagocytic killing and inhibition of bacterial motility. In addition, the combination of reFlgE with rePcrVNH, an engineered antigen we reported previously, provided elevated protection against PA infection. Our data demonstrate that FlgE is a promising vaccine candidate for PA and provide a new strategy for the efficient screening of antigens of other pathogens.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wan C, Gao C, Xie Q, et al. Flagella hook protein FlgE is a novel vaccine candidate of Pseudomonas aeruginosa identified by a genomic approach. Vaccine. 2021. PMID: 33775439. doi:10.1016/j.vaccine.2021.03.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。